Venetoclax with chemotherapy in relapse/refractory early T-cell precursor acute lymphoblastic leukemia

Leuk Lymphoma. 2021 Sep;62(9):2292-2294. doi: 10.1080/10428194.2021.1897807. Epub 2021 Mar 10.

Authors

Sankalp Arora¹, Pankit Vachhani², Kimo Bachiashvili², Omer Jamy²

Affiliations

¹ Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
² Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

PMID: 33691573
DOI: 10.1080/10428194.2021.1897807

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Bridged Bicyclo Compounds, Heterocyclic / therapeutic use
Humans
Precursor Cells, T-Lymphoid*
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
Recurrence
Sulfonamides

Substances

Bridged Bicyclo Compounds, Heterocyclic
Sulfonamides
venetoclax